Selectins—The Two Dr. Jekyll and Mr. Hyde Faces of Adhesion Molecules—A Review

Selectins belong to a group of adhesion molecules that fulfill an essential role in immune and inflammatory responses and tissue healing. Selectins are glycoproteins that decode the information carried by glycan structures, and non-covalent interactions of selectins with these glycan structures medi...

Full description

Bibliographic Details
Main Authors: Igor Tvaroška, Chandrabose Selvaraj, Jaroslav Koča
Format: Article
Language:English
Published: MDPI AG 2020-06-01
Series:Molecules
Subjects:
Online Access:https://www.mdpi.com/1420-3049/25/12/2835
_version_ 1797564725987377152
author Igor Tvaroška
Chandrabose Selvaraj
Jaroslav Koča
author_facet Igor Tvaroška
Chandrabose Selvaraj
Jaroslav Koča
author_sort Igor Tvaroška
collection DOAJ
description Selectins belong to a group of adhesion molecules that fulfill an essential role in immune and inflammatory responses and tissue healing. Selectins are glycoproteins that decode the information carried by glycan structures, and non-covalent interactions of selectins with these glycan structures mediate biological processes. The sialylated and fucosylated tetrasaccharide sLe<sup>x</sup> is an essential glycan recognized by selectins. Several glycosyltransferases are responsible for the biosynthesis of the sLe<sup>x</sup> tetrasaccharide. Selectins are involved in a sequence of interactions of circulated leukocytes with endothelial cells in the blood called the adhesion cascade. Recently, it has become evident that cancer cells utilize a similar adhesion cascade to promote metastases. However, like Dr. Jekyll and Mr. Hyde’s two faces, selectins also contribute to tissue destruction during some infections and inflammatory diseases. The most prominent function of selectins is associated with the initial stage of the leukocyte adhesion cascade, in which selectin binding enables tethering and rolling. The first adhesive event occurs through specific non-covalent interactions between selectins and their ligands, with glycans functioning as an interface between leukocytes or cancer cells and the endothelium. Targeting these interactions remains a principal strategy aimed at developing new therapies for the treatment of immune and inflammatory disorders and cancer. In this review, we will survey the significant contributions to and the current status of the understanding of the structure of selectins and the role of selectins in various biological processes. The potential of selectins and their ligands as therapeutic targets in chronic and acute inflammatory diseases and cancer will also be discussed. We will emphasize the structural characteristic of selectins and the catalytic mechanisms of glycosyltransferases involved in the biosynthesis of glycan recognition determinants. Furthermore, recent achievements in the synthesis of selectin inhibitors will be reviewed with a focus on the various strategies used for the development of glycosyltransferase inhibitors, including substrate analog inhibitors and transition state analog inhibitors, which are based on knowledge of the catalytic mechanism.
first_indexed 2024-03-10T19:02:03Z
format Article
id doaj.art-3a182c2ad9f34c8ebc8103db326efde7
institution Directory Open Access Journal
issn 1420-3049
language English
last_indexed 2024-03-10T19:02:03Z
publishDate 2020-06-01
publisher MDPI AG
record_format Article
series Molecules
spelling doaj.art-3a182c2ad9f34c8ebc8103db326efde72023-11-20T04:22:12ZengMDPI AGMolecules1420-30492020-06-012512283510.3390/molecules25122835Selectins—The Two Dr. Jekyll and Mr. Hyde Faces of Adhesion Molecules—A ReviewIgor Tvaroška0Chandrabose Selvaraj1Jaroslav Koča2Central European Institute of Technology (CEITEC), Masaryk University, 62500 Brno, Czech RepublicCentral European Institute of Technology (CEITEC), Masaryk University, 62500 Brno, Czech RepublicCentral European Institute of Technology (CEITEC), Masaryk University, 62500 Brno, Czech RepublicSelectins belong to a group of adhesion molecules that fulfill an essential role in immune and inflammatory responses and tissue healing. Selectins are glycoproteins that decode the information carried by glycan structures, and non-covalent interactions of selectins with these glycan structures mediate biological processes. The sialylated and fucosylated tetrasaccharide sLe<sup>x</sup> is an essential glycan recognized by selectins. Several glycosyltransferases are responsible for the biosynthesis of the sLe<sup>x</sup> tetrasaccharide. Selectins are involved in a sequence of interactions of circulated leukocytes with endothelial cells in the blood called the adhesion cascade. Recently, it has become evident that cancer cells utilize a similar adhesion cascade to promote metastases. However, like Dr. Jekyll and Mr. Hyde’s two faces, selectins also contribute to tissue destruction during some infections and inflammatory diseases. The most prominent function of selectins is associated with the initial stage of the leukocyte adhesion cascade, in which selectin binding enables tethering and rolling. The first adhesive event occurs through specific non-covalent interactions between selectins and their ligands, with glycans functioning as an interface between leukocytes or cancer cells and the endothelium. Targeting these interactions remains a principal strategy aimed at developing new therapies for the treatment of immune and inflammatory disorders and cancer. In this review, we will survey the significant contributions to and the current status of the understanding of the structure of selectins and the role of selectins in various biological processes. The potential of selectins and their ligands as therapeutic targets in chronic and acute inflammatory diseases and cancer will also be discussed. We will emphasize the structural characteristic of selectins and the catalytic mechanisms of glycosyltransferases involved in the biosynthesis of glycan recognition determinants. Furthermore, recent achievements in the synthesis of selectin inhibitors will be reviewed with a focus on the various strategies used for the development of glycosyltransferase inhibitors, including substrate analog inhibitors and transition state analog inhibitors, which are based on knowledge of the catalytic mechanism.https://www.mdpi.com/1420-3049/25/12/2835selectinsselectin ligandscarbohydrate determinantssialyl Lewis xglycosyltransferasesinflammation
spellingShingle Igor Tvaroška
Chandrabose Selvaraj
Jaroslav Koča
Selectins—The Two Dr. Jekyll and Mr. Hyde Faces of Adhesion Molecules—A Review
Molecules
selectins
selectin ligands
carbohydrate determinants
sialyl Lewis x
glycosyltransferases
inflammation
title Selectins—The Two Dr. Jekyll and Mr. Hyde Faces of Adhesion Molecules—A Review
title_full Selectins—The Two Dr. Jekyll and Mr. Hyde Faces of Adhesion Molecules—A Review
title_fullStr Selectins—The Two Dr. Jekyll and Mr. Hyde Faces of Adhesion Molecules—A Review
title_full_unstemmed Selectins—The Two Dr. Jekyll and Mr. Hyde Faces of Adhesion Molecules—A Review
title_short Selectins—The Two Dr. Jekyll and Mr. Hyde Faces of Adhesion Molecules—A Review
title_sort selectins the two dr jekyll and mr hyde faces of adhesion molecules a review
topic selectins
selectin ligands
carbohydrate determinants
sialyl Lewis x
glycosyltransferases
inflammation
url https://www.mdpi.com/1420-3049/25/12/2835
work_keys_str_mv AT igortvaroska selectinsthetwodrjekyllandmrhydefacesofadhesionmoleculesareview
AT chandraboseselvaraj selectinsthetwodrjekyllandmrhydefacesofadhesionmoleculesareview
AT jaroslavkoca selectinsthetwodrjekyllandmrhydefacesofadhesionmoleculesareview